MYB-NFIB gene fusion in adenoid cystic carcinoma of the breast with special focus paid to the solid variant with basaloid features
- 1 November 2014
- journal article
- Published by Elsevier in Human Pathology
- Vol. 45 (11) , 2270-2280
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Rare Breast Cancer: 933 Adenoid Cystic Carcinomas from the National Cancer Data BaseAnnals of Surgical Oncology, 2013
- Heterogeneity of Triple-Negative Breast Cancer: Histologic Subtyping to Inform the OutcomeClinical Breast Cancer, 2013
- Novel Chromosomal Rearrangements and Break Points at the t(6;9) in Salivary Adenoid Cystic Carcinoma: Association with MYB–NFIB Chimeric Fusion, MYB Expression, and Clinical OutcomeClinical Cancer Research, 2011
- Adenoid Cystic Breast Carcinoma: Is Axillary Staging Necessary in All Cases? Results from the California Cancer RegistryThe Breast Journal, 2011
- MYB Expression and Translocation in Adenoid Cystic Carcinomas and Other Salivary Gland Tumors With Clinicopathologic CorrelationAmerican Journal of Surgical Pathology, 2011
- Adenoid cystic carcinoma of the breast in the United States (1977 to 2006): a population-based cohort studyBreast Cancer Research, 2010
- Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neckProceedings of the National Academy of Sciences, 2009
- MYB function in normal and cancer cellsNature Reviews Cancer, 2008
- Basaloid carcinoma of the breast: a review of 9 cases, with delineation of a possible clinicopathologic entityAnnals of Diagnostic Pathology, 2008
- pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐upHistopathology, 1991